Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRRC34 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | EML2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | TTC13 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | RAB1A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | PSMD6 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ACD | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | TMEM39A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | C2CD4C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | AAMP | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | TIGD6 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |